NVNO - enVVeno Medical Corp
12.08
0.380 3.146%
Share volume: 14,480
Last Updated: 04-20-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$11.70
0.38
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 07-31-2024 | 10-30-2024 | 02-28-2025 | 04-30-2025 | 07-31-2025 | 10-30-2025 | 03-26-2026 | |
| Assets | |||||||||
| Total Assets | 44.829 M | 40.995 M | 50.390 M | 44.954 M | 40.577 M | 36.577 M | 32.352 M | 29.562 M | |
| Current Assets | 43.248 M | 39.536 M | 49.051 M | 43.734 M | 39.479 M | 35.604 M | 31.499 M | 28.826 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 40.628 M | 36.687 M | 30.464 M | 41.399 M | 36.004 M | 33.098 M | 29.408 M | 25.147 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.314 M | 2.380 M | 17.915 M | 1.754 M | 2.937 M | 2.044 M | 1.544 M | 3.065 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 289.000 K | 252.000 K | 218.000 K | 182.000 K | 142.000 K | 113.000 K | 82.000 K | 51.000 K | |
| Other Assets | 1.292 M | 1.207 M | 1.121 M | 1.038 M | 956.000 K | 860.000 K | 771.000 K | 685.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 44.829 M | 40.995 M | 50.390 M | 44.954 M | 40.577 M | 36.577 M | 32.352 M | 29.562 M | |
| Total liabilities | 2.460 M | 2.577 M | 3.020 M | 2.795 M | 2.270 M | 3.520 M | 2.905 M | 2.432 M | |
| Total current liabilities | 1.487 M | 1.695 M | 2.229 M | 2.095 M | 1.661 M | 3.015 M | 2.400 M | 2.122 M | |
| Accounts Payable | 1.143 M | 1.344 M | 1.872 M | 1.731 M | 1.291 M | 2.638 M | 2.114 M | 1.732 M | |
| Other liabilities | 973.000 K | 882.000 K | 791.000 K | 700.000 K | 609.000 K | 505.000 K | 505.000 K | 310.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 973.000 K | 882.000 K | 791.000 K | 700.000 K | 609.000 K | 505.000 K | 505.000 K | 310.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 42.369 M | 38.418 M | 47.370 M | 42.159 M | 38.307 M | 33.057 M | 29.447 M | 27.130 M | |
| Common stock | 177.397 M | 178.402 M | 192.996 M | 194.014 M | 194.665 M | 196.109 M | 197.038 M | 198.457 M | |
| Retained earnings | -135.028 M | -139.984 M | -145.626 M | -151.855 M | -156.358 M | -163.052 M | -167.591 M | -171.327 M |